# FDA Inspection 1008990 - Octapharma Plasma Inc - March 16, 2017

Source: https://www.globalkeysolutions.net/records/fda_inspections/octapharma-plasma-inc/dcb5195e-b50c-46ce-91e1-0c3c3019e8aa
Source feed: FDA_Inspections

> FDA Inspection 1008990 for Octapharma Plasma Inc on March 16, 2017. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1008990
- Company Name: Octapharma Plasma Inc
- Inspection Date: 2017-03-16
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1153683 - 2021-09-23](https://www.globalkeysolutions.net/records/fda_inspections/octapharma-plasma-inc/99ac30f8-92a7-411e-833f-5a75a2e7b5c5)
- [FDA Inspection 1153683 - 2021-09-23](https://www.globalkeysolutions.net/records/fda_inspections/octapharma-plasma-inc/f2877e10-621c-4684-8c28-367dbae8b0e2)
- [FDA Inspection 916482 - 2015-03-05](https://www.globalkeysolutions.net/records/fda_inspections/octapharma-plasma-inc/8e20f761-b640-435f-8cd9-e4639ac64a29)
- [FDA Inspection 757171 - 2011-12-15](https://www.globalkeysolutions.net/records/fda_inspections/octapharma-plasma-inc/6f778af3-a745-4c93-861c-d40f0b5a2099)
- [FDA Inspection 649786 - 2010-03-03](https://www.globalkeysolutions.net/records/fda_inspections/octapharma-plasma-inc/faea97b3-6171-4415-9c88-60c7f7d48703)

Company: https://www.globalkeysolutions.net/companies/octapharma-plasma-inc/ef2ccde6-5421-4a92-a9b1-c99257232e8e

Office: https://www.globalkeysolutions.net/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d
